期刊文献+

动态增强MRI评估抗利尿激素缺乏大鼠肾功能的实验研究 被引量:1

Evaluation of kidney function in vasopressin-deficient rats by using dynamic enhanced MRI
原文传递
导出
摘要 目的探讨动态增强MRI检查判断抗利尿激素(AVP)缺乏大鼠梗阻肾功能及对AVP治疗的反应。方法3月龄Brattleboro(BB)鼠26只。其中建立单侧输尿管梗阻(UUO)模型12只,24h后解除梗阻。uu0和无梗阻鼠各7只行AVP治疗6d,无梗阻BB鼠和正常Wistar鼠各7只作为对照组。采用动态增强MRI检测肾皮质、髓质和肾盂的相对信号强度(RSI)和肾血流量(RBF)。结果1min时BB鼠肾皮质RSI峰值(149±10)%、髓质(155±13)%、肾盂(146±13)%,而后肾皮质RSI曲线缓慢下降,峰值明显低于Wistar鼠(P〈0.05)。AVP治疗后30S时BB鼠肾皮质、髓质和肾盂的RSI均升至(180±6)%,RSI曲线接近正常Wistar鼠RSI曲线。在UUO组肾髓质和肾盂RSI曲线较无梗阻组上升缓慢。uu0解除后,AVP治疗使梗阻鼠肾脏RSl变化曲线明显恢复,接近正常肾脏RSI变化曲线。uuO使RBF降至(1.1士0.1)ml·min^-1·100g^-1,注射AVP6d后RBF升至(1.9±0.3)ml·min^-1·100g^-1。结论BB鼠肾脏AVP治疗前后动态增强MRI的RSI曲线明显不同,提示MRI检查可以判断BB鼠梗阻肾功能及对AVP治疗的反应,为评估肾功能及区别肾脏是否梗阻提供重要信息。 Objective To evaluate the renal function response to vasopressin in obstructed and non-obstructed kidney in vasopressin-deficient rats by using dynamic enhanced MRI. Methods This study included 26 vasopressin deficient Brattleboro (BB) rats. Unilateral ureteral obstruction (UUO) model was set up in 12 BB rats. After releasing UUO 24 h, treatment of AVP was given in 7 non-obstructed and 7 obstructed BB rats for 6 d. Seven normal Wistar rats and 7 BB rats were used as control. Dynamic enhanced MRI was performed at 0--60 rain following the administration of Gadolinium- DTPA(0.05 mmol/kg) and the mean relative signal intensity (RSI)was measured. Results BB rats RSI increase occurred during the first minute, with a maximum mean RSI of (149±10)% in cortex, (155±13)% in medulla and (146±13)% in pelvis. Then, a gradual decrease in the cortical RSI occurred, after which a small increase was observed in Phase 3. BB rats RSI patterns were different from Wistar rats. After AVP treatment, mean RSI of BB rats in cortex, medulla and pelvis reached a maximum of (180±6)%, respectively at 30 sec, followed by a fast decrease at 1 min. Then, RSI decreased gradually. Phase 3 demonstrated a moderate increase in medullary and a relative large increase in pelvic RSI until 30 min after injection, after which RSI returned to baseline. BB rats RSI patterns after AVP treatment were similar to that of Wistar rats. Cortical, medullary and pelvic mean RSI increased slowly compared to non UUO rats. In phase 3, mean RSI of all segments decreased gradually. UUO rats RSI patterns were different from non UUO rats. After AVP treatment in UUO rats, mean RSIs of all segments increased faster compared to UUO rats without AVP. Cortical mean RSI reached a maximum of (193±7) % at 2 min. Mean RSI of medulla were unchanged, but the pelvic mean RSI decreased gradually to a minimum of (77±5)% at 5 rain. Phase 3 was characterized by a slight recovery of all RSIs. UUO rats RSIs were recovered after AVP treatment. The renal blood flow(RBF) of UUO rats was decreased to(1. 1±0. 1)ml·min^-1·100g^-1, wherease the RBF was increased to (1.9±0.3)ml·min^-1·100g^-1 after injecting AVP. Conclusion Dynamic enhanced MRI may provide useful information for distinguishing between kidneys having changes in the renal vasopressin concentration and the kidneys suffer from the obstructed renal damage.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2009年第8期532-535,共4页 Chinese Journal of Urology
基金 国家自然科学基金资助项目(30571931) 河南省医学科技攻关计划资助项目(200801002) 郑州市技术研究与开发经费支持项目(074SGHH32262)志谢 丹麦AARHUS大学临床医学院MR中心M Pedersen,J Frokiaer和JC Djurhuus教授提供实验动物和技术支持
关键词 磁共振成像 肾功能 大鼠 Brattleboro 血管升压素类 Magnetic resonance image Kidney function Rrats brattleboro Vasopressins
  • 相关文献

参考文献14

  • 1DiGiovanni SR, Nielsen S, Christensen El, et al. Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat. PNAS,1994, 91:8984-8988.
  • 2Amlal H, Sheriff S, Faroqui S, et al. Regulation of acid-base transporters by vasopressin in the kidney collecting duct of Brattleboro rat. Am J Nephrol, 2006, 26:194-205.
  • 3Wen JG, Ringgaard S, Frokiaer J, et al. Contralateral corn pensatory kidney growth in rats with partial unilateral ureter al obstruction monitored by magnetic resonance imaging Urol, 1999, 162: 1084-1089.
  • 4Wen JG, Chen Y, Ringgaard S, et al. Evaluation of renal function in normal and hydronephrotic kidneys in rats using gadolinium diethylenetetraminepentaacetic acid enhanced dy namic magnetic resonance imaging. J Urol, 2000, 163: 1264-1270.
  • 5文建国.Gd-DTPA增强动态核磁共振诊断输尿管不全梗阻的实验研究[J].中华小儿外科杂志,2002,23(1):49-52. 被引量:6
  • 6文建国.Gd-DTPA增强动态核磁共振和动态核素肾扫描评估幼猪正常和梗阻肾脏[J].中华小儿外科杂志,2003,24(6):541-544. 被引量:2
  • 7Zhou Y, Coote JH. Autonomic neuroscience: paraventrieular nucleus influence on renal sympathetic activity in vasopressin gene-deleted rats. Exp Physiol, 2008, 92: 109-117.
  • 8Russo LM, McKee M, Brown D. Methyl-β-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat 'kidney. Am J Physiol Renal Physiol, 2006, 291: 246-253.
  • 9艾虎,孙福成.卡托普利肾动态显像诊断肾动脉狭窄的临床应用[J].中国心血管杂志,2008,13(5):374-376. 被引量:3
  • 10Petrovic S, Amlal H, Sun XM, et al. Vasopressin induces expression of the Cl-/HCO3- exchanger SLC26A7 in kidney medullary collecting ducts of Brattleboro rats. Am J Physiol Renal Physiol, 2006, 290:1194-1201.

二级参考文献31

  • 1Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: A systematic review. Ann Intern Med,2006,145:901-912.
  • 2Blaufox MD,Fine EJ,Heller S,et al. Prospective study of simultaneous orthoiodohippurate and diethylenetriaminepentaacetic acid captopril renography. J Nucl Med, 1998,39:522-528.
  • 3Dondi M, Monetti N, Fanti S, et al. Use of technetium-99m-MAG3 for renal scintigraphy after angiotensin-converting enzyme inhibition. J Nucl Med, 1991,32:424-428.
  • 4Blaufox MD, Dubovsky EV, Hilson AJ, et al. Report of the working party group on determining the radionuclide of choice. Am J Hypertens, 1991,4:747 -748.
  • 5Taylor AT Jr, Fletcher JW, Nally JV Jr, et al. Procedure guideline for diagnosis of renovascular hypertension. J Nucl Med, 1998,39: 1297-1302.
  • 6Setaro JF, Chen CC, Hoffer PB, et al. Captopril renography in the diagnosis of renal artery stevtosis and the prediction of improvement with revascularization. Am J Hypertens, 1991,4:698-705.
  • 7Ludwig V, Martin WH, Delbeke D. Calcium channel blockers: a potential cause of false-positive captopril renography. Clin Nucl Med ,2005,28 : 108-112.
  • 8Claveau-Tremblay R, Turpin S, De Braekeleer M, et al. Falsepositive captopril renography in patients taking calcium antagonists. J Nucl Med, 1998,39 : 1621-1626.
  • 9Bongers V, Bakker J, Beutler JJ, et al. Assessment of renal artery stenosis:comparison of captopril renography and gadolinium-enhanced breath-hold MR angiography. Clin Radiol,2000,55:346- 353.
  • 10Hirsch AT,Haskal ZJ, Hertzer NR,et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease ( lower extremity, renal, mesenteric, and abdominal aortic) :a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions,Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines. Circulation ,2006, 113:463-654.

共引文献8

同被引文献12

  • 1Ivanova LN, Kabilova NO. The effect of vasopressin and its analogs on hyaluronan-synthase type 2 gene expression in Wistar and vasopressin - deficient Brattleboro rat kidney[ J]. Ross Fiziol Zh lm 1 M Sechenova, 2009,95 (7) :694 - 705.
  • 2Kirsch A J, McMann LP, Jones RA, et al. Magnetic resonance urography for evaluating outcomes after pediatric pyeloplasty [ J ]. J Urol,2006,176 (4 Pt 2) :1755 - 1761.
  • 3Calder AD, Hioms MP, Abhyankar A, et al. Contrast - enhanced magnetic resonance angiography for the detection of crossing renal vessels in children with symptomatic ureteropelvic junction obstruction:Comparison with operative findings[ J]. Pediatr Radiol,2007,37(4) :356 -361.
  • 4Wen JG, Wang GX, Chen Y, et al. Long - term EGF treatment partially prevents reduction of renal blood flow in response to neonatally induced partial unilateral uretera obstruction [ J ]. Nephron Exp Nephrol, 2009, 111 (2) :e51 - e59.
  • 5Zhou Y, Coote JH. Paraventricular nucleus influence on renal sympathetic activity in vasopressin gene -deleted rats[ J]. Exp Physiol,2008,92 (1) :109 -117.
  • 6Ivanova LN, Kabilova NO, Bondar AA. Effect of dDAVP, agonist of V2 vasopressin receptor on the hyaluronidase - 1 and hyalumnidase - 2 gene expression in the kidneys of Wistar and Brattleboro rats[ J]. Ross Fiziol Zh Im I M Sechenova ,2007,93 (5) :494 - 504.
  • 7Ivanova LN, Lavrinenko VA, Babina AV, et al. Structure and concentration capacity of the kidneys in brattleboro rats under conditions of long - term vasopressin treatment[ J]. Bull Exp Biol Med,2008,146(5 ) :642 - 646.
  • 8Kuperman VY, Karczmar GS, Blomley M J, et al. Differentiating between T1 and T2 * changes caused by gadopentetate dimeglumine in the kidney by using a double - echo dynamic MR imaging sequence[ J]. J Magn Reson Imaging, 1996,6 (5) :764 - 768.
  • 9Saito T, Ishikawa S, Sasaki S, et al. Lack of vasopressin -independent upregulation of AQP - 2 gene expression in homozygous Brattleboro rats [ J 1. Am J Physiol, 1999,277 (2 Pt 2 ) : R427 - R433.
  • 10Hoffert JD, Nielsen J, Yu M J, et al. Dynamics of aquaporin -2 serine - 261 phosphorylation in response to short - term vasopressin treatment in collecting duct [J]. Am J Physiol Renal Physiol,2007,292 (2) :691 - 700.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部